Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 17Neoplasms 9Head and Neck Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 5Pancreatic Neoplasms 4Endometrial Neoplasms 4Urinary Bladder Neoplasms 3Rectal Neoplasms 3Oropharyngeal Neoplasms 3Motor Activity 3Kidney Neoplasms 3Health Behavior 3Depression 3Carcinoma, Squamous Cell 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Smoking Cessation 2Multiple Myeloma 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Fallopian Tube Neoplasms 2Communication 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Carcinoma, Renal Cell 2Anxiety Disorders 2Alopecia 2Xerostomia 1

Interventions

Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡